French Database of Left Atrial Appendage Closure
- Conditions
- Atrial Fibrillation and Other Dysrhythmias | Patient
- Interventions
- Other: Percutaneous Left Atrial Appendage Closure in routine care
- Registration Number
- NCT02252861
- Lead Sponsor
- Henri Mondor University Hospital
- Brief Summary
Patients with atrial fibrillation are exposed to a high risk of thrombus in the left atrium that can induce cerebral vascular events or systemic embolisms. This justifies the prescription of anticoagulant therapies in patients with high risk of thromboembolic event. Percutaneous left atrial appendage closure is a new interventional strategy for patients with high risk of cardiovascular events and a counter-indication for long term treatment with anticoagulant agents. However, only few data are available on effectiveness and prognosis of patients treated by this new interventional strategy.
This national database record per-procedure and follow-up data of patients treated by left atrial appendage closure.
This database is strictly observational.
Percutaneous left atrial appendage closure is performed only for the purpose of patient care. No specific intervention is performed specifically for the database. Neither left atrial appendage closure procedure nor patient follow up are modified by patient inclusion in the database.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 840
- Patients referred to a french interventional cardiology department for percutaneous left atrial appendage closure in routine care
- Signature of an inform consent form for inclusion of data recorded during care in the database
none
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Left Atrial Appendage Closure Percutaneous Left Atrial Appendage Closure in routine care Patients with atrial fibrillation and counter-indication to anticoagulant therapy referred for percutaneous Left Atrial Appendage Closure in routine care
- Primary Outcome Measures
Name Time Method Assessment of the rate of thromboembolic events related to atrial fibrillation in patients treated by left atrial appendage closure in daily practice in France 1 year
- Secondary Outcome Measures
Name Time Method Unexplained Death rate after left atrial appendage closure 1 year Cost of patient follow-up after left atrial appendage closure 1 year Assessment of patient management in daily practice after left atrial appendage closure (number of echocardiography procedures) 1 year Death rate from cardiovascular disease after left atrial appendage closure 1 year Adverse events related to the procedure 1 year Cost of the procedure of left atrial appendage closure Costs will be assessed for the duration of hospital stay, an expected average of 3 days Assessment of patient medical treatment in daily practice after left atrial appendage closure (percentage of patients with antiplatelet drugs) 1 year
Trial Locations
- Locations (1)
Henri Mondor Hospital
🇫🇷Creteil, France